[48] The role of penile rehabilitation for Peyronie’s disease, does it really work?
Objective: To assess the role of penile rehabilitation for Peyronie’s disease (PD). PD causes penile deformity and erectile dysfunction (ED) in sexually active men with an incidence of 3–9%. Penile rehabilitation is recommended (European Association of Urology 2016) to limit the progression of the d...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Taylor & Francis Group
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/2eaa67c07d934d2c96c15f3ea3858e90 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Objective: To assess the role of penile rehabilitation for Peyronie’s disease (PD). PD causes penile deformity and erectile dysfunction (ED) in sexually active men with an incidence of 3–9%. Penile rehabilitation is recommended (European Association of Urology 2016) to limit the progression of the disease. Methods: A single-centre analysis of the management of patients with PD over a 2-year period. Data were collected retrospectively via case note review. Results: A total of 68 new patients were seen from July 2015 to October 2017, with a mean (range) age of 55 (23–74) years. All patients were asked to complete a Peyronie’s Disease Questionnaire (PDQ). Penile deformity ranged between 20 and 60°. Vacuum treatment (SOMAcorrect©, iMEDicare Ltd, Watford, UK) was offered in 51 patients as primary therapy. Surgery was offered as primary treatment in 10 patients, and seven patients were discharged with no treatment. In those that received vacuum treatment, subjective improvement was seen in 49% (25 patients). In this group, there was a significant increase in the ability to perform penetrative intercourse, 48% (12 patients). Those that failed SOMAcorrect therapy were offered surgery (26 patients) in the form of Nesbitt’s procedure. The failure group showed only a 38% improvement in the ability to perform penetrative intercourse pre-surgery. In all, 10 patients were offered Nesbitt’s as a primary treatment method with a 60% improvement in ability to perform penetrative intercourse. Pre-treatment mean curvature in those that improved with SOMAcorrect was noted to be 38°. In contrast, those that failed SOMAcorrect or underwent primary surgery had a pre-treatment angle of 44–45°. Conclusion: SOMAcorrect is a valuable tool in select patients to treat PD. It has the potential to prevent significant surgical intervention in a large proportion of patients with minimal adverse effects. Preliminary results show comparable efficacy to surgery with a minimally invasive approach. Subjective outcomes are promising, and it should be considered as primary treatment method in appropriate patients. |
|---|